HWM
BIIB icon

Hemington Wealth Management’s Biogen BIIB Stock Holding History

Hemington Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$8K Buy
59
+14
+31% +$1.89K ﹤0.01% 952
2025
Q2 		$5K Sell
45
-25
-36% -$3.12K ﹤0.01% 1071
2025
Q1 		$9K Sell
70
-2
-3% -$286 ﹤0.01% 835
2024
Q4 		$11K Sell
72
-10
-12% -$1.69K ﹤0.01% 726
2024
Q3 		$14K Buy
+82
New +$17.2K ﹤0.01% 601

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Hemington Wealth Management's BIIB Position: Q3 2025 in Review

Hemington Wealth Management increased its Biogen (BIIB) stake by 31% in Q3 2025, buying an estimated $1.89K and bringing the position to 59 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #952.

Hemington Wealth Management first reported a position in BIIB in Q3 2024 and has held it in 5 quarters since. The position peaked at $14K in Q3 2024. 908 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • Hemington Wealth Management held 59 shares of Biogen worth $8K as of Q3 2025.
  • Hemington Wealth Management bought 14 Biogen shares in Q3 2025, an estimated $1.89K.
  • Biogen made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #952 holding.
  • Hemington Wealth Management first reported a position in Biogen in Q3 2024 and has held it in 5 quarters since.
  • Hemington Wealth Management's Biogen position peaked at $14K in Q3 2024.
  • 908 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.